Atlas Venture Associates IX, LLC - Q3 2021 holdings

$301 Million is the total value of Atlas Venture Associates IX, LLC's 7 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .

 Value Shares↓ Weighting
SKLZ  SKILLZ INC$224,975,000
-54.8%
22,909,8590.0%74.78%
-14.6%
SPRO  SPERO THERAPEUTICS INC$25,350,000
+31.9%
1,376,9680.0%8.43%
+149.1%
SURF  SURFACE ONCOLOGY INC$22,297,000
+1.5%
2,945,4530.0%7.41%
+91.7%
SNAP  SNAP INCcl a$11,092,000
+8.4%
150,1600.0%3.69%
+104.8%
SYBX  SYNLOGIC INC$8,088,000
-21.6%
2,651,9630.0%2.69%
+48.1%
COGT  COGENT BIOSCIENCES INC$7,711,000
+3.7%
916,8320.0%2.56%
+95.9%
NTLA  INTELLIA THERAPEUTICS INC$1,342,000
-17.1%
10,0000.0%0.45%
+56.5%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-04
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTELLIA THERAPEUTICS INC28Q3 2023100.0%
SNAP INC26Q3 202311.4%
SPERO THERAPEUTICS INC24Q3 202324.0%
SYNLOGIC INC24Q2 202335.6%
SURFACE ONCOLOGY INC21Q2 202333.3%
SKILLZ INC12Q3 202387.5%
UNUM THERAPEUTICS INC11Q3 202028.2%
COGENT BIOSCIENCES INC7Q2 20229.6%
CARBON BLACK INC6Q3 20197.8%
COHERUS BIOSCIENCES INC1Q3 202318.1%

View Atlas Venture Associates IX, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04
13F-HR2021-08-11

View Atlas Venture Associates IX, LLC's complete filings history.

Compare quarters

Export Atlas Venture Associates IX, LLC's holdings